Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts payable and accrued liabilities | 1,431 | 1,580 | -537 | 162 | -440 |
| Other Working Capital | 1,327 | 6,051 | 2,176 | -3,563 | -2,593 |
| Other Operating Activity | -12,814 | -11,485 | -6,565 | -5,315 | -3,638 |
| Operating Cash Flow | $-10,056 | $-3,854 | $-4,927 | $-8,715 | $-6,671 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,244 | 0 | 0 | 470 | 27,187 |
| Other Financing Activity | 701 | 0 | 0 | 0 | 28 |
| Financing Cash Flow | $20,945 | $0 | $0 | $470 | $27,216 |
| Beginning Cash Position | 4,510 | 8,364 | 13,291 | 21,537 | 992 |
| End Cash Position | 15,399 | 4,510 | 8,364 | 13,291 | 21,537 |
| Net Cash Flow | $10,889 | $-3,854 | $-4,927 | $-8,246 | $20,544 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,056 | -3,854 | -4,927 | -8,715 | -6,671 |
| Free Cash Flow | -10,056 | -3,854 | -4,927 | -8,715 | -6,671 |